Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis

Am J Trop Med Hyg. 2021 Oct 25;106(2):373-375. doi: 10.4269/ajtmh.21-0624.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abattoirs
  • Anti-Inflammatory Agents / therapeutic use
  • Antitubercular Agents / therapeutic use*
  • Clofazimine / therapeutic use
  • Dapsone / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Isoniazid / therapeutic use
  • Latent Tuberculosis / complications
  • Latent Tuberculosis / drug therapy
  • Leprostatic Agents / therapeutic use*
  • Leprosy, Borderline / complications
  • Leprosy, Borderline / diagnosis*
  • Leprosy, Borderline / drug therapy
  • Leprosy, Borderline / pathology
  • Leprosy, Multibacillary / complications
  • Leprosy, Multibacillary / diagnosis*
  • Leprosy, Multibacillary / drug therapy
  • Leprosy, Multibacillary / pathology
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Rifampin / therapeutic use
  • Thrombophlebitis / diagnosis

Substances

  • Anti-Inflammatory Agents
  • Antitubercular Agents
  • Leprostatic Agents
  • Dapsone
  • Prednisolone
  • Clofazimine
  • Isoniazid
  • Rifampin